| Literature DB >> 34072098 |
Ioana Corina Bocsan1, Raluca Maria Pop1, Octavia Sabin1, Elias Sarkandy1, Paul-Mihai Boarescu2, Ştefan Horia Roşian3,4, Poliana Mihaela Leru5,6, Veronica Sanda Chedea7, Sonia Ancuța Socaci8, Anca Dana Buzoianu1.
Abstract
The study's aim was to characterize the composition of Nigella sativa seed (NSO) and grape seed (GSO) oils, and to evaluate their cardioprotective and anti-inflammatory effect on isoproterenol (ISO)-induced ischemia in rats. Materials andEntities:
Keywords: anti-inflammatory; antioxidant; black cumin oil; cardiovascular disease; grape seed oil
Mesh:
Substances:
Year: 2021 PMID: 34072098 PMCID: PMC8198749 DOI: 10.3390/molecules26113221
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Physicochemical properties of NSO and GSO.
| No | Sample | Refractive | Iodine Index | Free Acidity | Peroxide Value |
|---|---|---|---|---|---|
| 1 | NSO | 1.466 | 70 | 1.2 | <10 |
| 2 | GSO | 1.478 | 67 | 4.4 | <10 |
Figure 1NSO and GSO general FTIR spectra (600–3100 cm−1). For peak assignment, see Table 2.
The tentative peak assignment for the general FTIR spectra (600–3100 cm−1) for NSO and GSO.
| No | Peak | Peak Intensity | Tentative | |
|---|---|---|---|---|
| NSO | GSO | |||
| 1 | 719 | 0.575 | 0.565 | CH=CH– bending out of plane |
| 2 | 866 | 0.141 | 0.131 | =CH2 wagging |
| 3 | 914 | 0.176 | 0.161 | –C–H bending out of plane |
| 4 | 968 | 0.186 | 0.170 | |
| 5 | 1028 | 0.217 | 0.209 | –C–O stretch |
| 6 | 1097 | 0.470 | 0.460 | –C–O stretch |
| 7 | 1161 | 0.794 | 0.776 | –C–O stretch; –CH2 bending |
| 8 | 1236 | 0.384 | 0.360 | –C–O stretch |
| 9 | 1375 | 0.223 | 0.203 | –C–H bending |
| 10 | 1460 | 0.369 | 0.332 | –CH2 bending |
| 11 | 1743 | 1 | 1 | C=O stretching |
| 12 | 2852 | 0.54 | 0.465 | –CH2 asymmetrical stretching |
| 13 | 2924 | 0.753 | 0.648 | –CH2 symmetrical stretching |
| 14 | 3008 | 0.154 | 0.151 | ( |
Gas chromatography coupled with mass spectroscopy (GS–MS) chemical composition of volatile compounds identified in NSO and GSO.
| No | Compounds | Retention Time | Concentration | |
|---|---|---|---|---|
| NSO | GSO | |||
| 1 | Hexanal | 4.024 | 0.98 | 36.68 |
| 2 | 1-Butanol, 3-methyl-, acetate | 5.995 | - | 48.55 |
| 3 | α-Thujene | 7.61 | 42.97 | - |
| 4 | α-Pinene | 7.853 | 8.25 | 3.16 |
| 5 | Camphene | 8.435 | 0.06 | - |
| 6 | Sabinene | 9.258 | 2.38 | - |
| 7 | β-Pinene | 9.439 | 4.96 | - |
| 9 | Furan, 2-pentyl- | 9.907 | - | 0.43 |
| 10 | Hexanoic acid, ethyl ester | 10.234 | - | 8.2 |
| 12 | α-Terpinene | 10.912 | 0.27 | - |
| 13 | 11.227 | 33.71 | - | |
| 14 | 11.383 | 2.07 | 0.75 | |
| 15 | Eucalyptol | 11.502 | 0.06 | - |
| 16 | γ-Terpinene | 12.504 | 0.64 | - |
| 17 | Terpinolene | 13.56 | 0.06 | - |
| 21 | Octanoic acid, ethyl ester | 17.874 | - | 1.34 |
| 22 | Thymoquinone | 19.84 | 1.9 | - |
| 23 | Cuminone | 20.651 | 0.4 | - |
Figure 2Comparative HPLC chromatograms of NSO and GSO. For peak assignment, see Table 4.
Tentative identification, characterization, and concentration of major compounds identified in NSO and GSO extracts.
| Peak | Rt (min) | UV λmax | [M + H]+ | Compound | Concentration | |
|---|---|---|---|---|---|---|
| NSO | GSO | |||||
| 1 | 12.15 | 275 | 139 | 0.807 | 0.971 | |
| 2 | 12.66 | 260 | 342 | Norargemonine | 1.167 | - |
| 3 | 12.75 | 280 | 291 | Catechin | - | 0.987 |
| 4 | 13.61 | 280 | 169 | Vanillic acid | - | 0.799 |
| 5 | 13.92 | 320 | 181 | Caffeic acid | - | 0.807 |
| 6 | 16.10 | 321 | 165 | - | 1.749 | |
| 7 | 16.82 | 322 | 195 | Ferulic acid | - | 1.519 |
| 8 | 17.40 | 350, 260 | 755 | Kaempferol-rhamnoside-diglucoside | - | 1.118 |
| 9 | 18.77 | 320 | 517 | Dicaffeoylquinic acid | - | 1.110 |
| 10 | 20.13 | 320 | 517 | Dicaffeoylquinic acid | - | 0.872 |
| 11 | 20.51 | 290 | 194 | Thymol derivative | 17.105 | - |
| 12 | 21.86 | 280 | 867, 291 | Procyanidin trimer possibly C2 | - | 1.413 |
| 13 | 23.29 | 350, 260 | 755 | K | 2.191 | - |
| 14 | 23.4 | 280 | 867, 291 | Procyanidin trimer | - | 2.281 |
| 15 | 23.75 | 280 | 375 | Hydroxymatairesinol | 6.687 | 5.852 |
| 16 | 24.00 | 280 | 358 | Matairesinol | 10.692 | 4.337 |
| 17 | 24.21 | 280 | 1099, 1085 | Tanin | 14.656 | 2.748 |
| 18 | 24.32 | 280 | 375 | Isohydroxymatairesinol | 12.076 | 6.990 |
| 19 | 24.59 | 280 | 1120 | Tanin | 3.927 | 3.878 |
| 20 | 24.99 | 290 | 150 | Tymol | 10.561 | - |
| 21 | 25.51 | 280 | 414 | Tymol derivative | 8.382 | - |
| 22 | 26.03 | 280 | 1142 | Tanin | 11.364 | - |
| 23 | 26.18 | 280 | 1040 | Tanin | 7.645 | - |
Basal values of ECG parameters recorded at the beginning of the experiment. C (control group), C-ISO (ISO group), NSO + ISO (Nigella sativa seed oil and ISO group), GSO + ISO (grape seed oil and ISO group), HR (heart rate).
| Group | HR (Beats/min) | RR (ms) | PR | QRS | QT | QTc | R |
|---|---|---|---|---|---|---|---|
| C | 282 ± 19 | 223 ± 17 | 42 ± 2 | 34 ± 2 | 78 ± 3 | 65 ± 3 | 2.1 ± 0.1 |
| C-ISO | 287 ± 19 | 237 ± 16 | 41 ± 2 | 34 ± 4 | 78 ± 4 | 65 ± 3 | 2.1 ± 0.1 |
| NSO + ISO | 288 ± 15 | 225 ± 11 | 42 ± 2 | 35 ± 4 | 80 ± 4 | 65 ± 4 | 2.1 ± 0.1 |
| GSO + ISO | 283 ± 16 | 230 ± 9 | 42 ± 2 | 35 ± 4 | 78 ± 4 | 64 ± 3 | 2.1 ± 0.1 |
Figure 3Normal EGC record from first day of experiment.
ECG parameters recorded after MI (day 14). C (control group), C-ISO (ISO group), NSO + ISO (Nigella sativa seed oil and ISO group), GSO + ISO (grape seed oil and ISO group), HR (heart rate).
| Group | HR (Beats/min) | RR (ms) | PR | QRS | QT | QTc | R |
|---|---|---|---|---|---|---|---|
| C | 271 ± 18 | 220 ± 16 | 42 ± 2 | 34 ± 2 | 78 ± 3 | 634 ± 4 | 2.1 ± 0.1 |
| C-ISO | 329 ± 15 | 186 ± 9 | 45 ± 2 | 53 ± 4 | 104 ± 63 | 94 ± 6 | 0.8 ± 0.1 |
| NSO + ISO | 315 ± 6 | 190 ± 4 | 43 ± 2 | 53 ± 4 | 95 ± 4 | 85 ± 3 | 1.1 ± 0.1 |
| GSO + ISO | 299 ± 15 | 201 ± 11 | 43 ± 2 | 49 ± 7 | 95 ± 4 | 82 ± 4 | 1.2 ± 0.1 |
Figure 4The ECG records in experimental groups with (A) C group, (B) C-ISO group, (C) NSO + ISO group, and (D) GSO + ISO on day 15 after MI induction 24 h after ISO administration (groups 2 to 4): increased RR interval (black arrow), ST-segment depression (green arrow), QT interval prolongation (blue arrow). The amplitude of these changes was different in the experimental groups.
Figure 5ALT (A) and AST (B) serum levels in the experimental groups.
Figure 6Serum levels of cardiac enzymes CK-MB (A) and troponin (B) in the experimental groups.
Figure 7Serum levels of inflammatory markers IL6 (A), IL 1beta (B) and TNF-alpha (C) in the experimental groups.